Avammune Therapeutics - Company Profile & Overview
Founded in 2020, Avammune Therapeutics operates in Health Tech industry. Initially focused on developing cutting-edge therapies for immune-related disorders, the company has evolved to offer personali...
Funding stage:
Series A
Last funding:
11/05/2025
Total funding:
$12.00 Mn+
Investors
Employee count:
16
Last 90d
16
Last 90d
Web traffic:
558
558
Last 30d
Last 30d
FAQs on Avammune Therapeutics
Avammune Therapeutics was founded by Arun B Papaiah, Srinivasan Namala,Aditya Kulkarni in 2020.
Health Tech startup Avammune Therapeutics has raised a total funding of $12.00 million across 3 funding rounds. The last round of funding was raised on 12 May 2025. Find the details around funding rounds, participating investors, and other insights of Avammune Therapeutics here...
Avammune Therapeutics is Health Tech startup based out of Philadelphia.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links